Comparison of validity of standard nonclinical group size selection versus standard clinical group sizes for nonhuman primate QTc prolongation evaluation.

MLA

Holdsworth, David, et al. “Comparison of Validity of Standard Nonclinical Group Size Selection versus Standard Clinical Group Sizes for Nonhuman Primate QTc Prolongation Evaluation.” Journal of Pharmacological & Toxicological Methods, vol. 120, Mar. 2023, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.vascn.2023.107253.

APA

Holdsworth, D., Best, D. D., Haist, K., O’Donohue, K., Phillips, A., Abernathy, M. M., Roche, B., & Leishman, D. J. (2023). Comparison of validity of standard nonclinical group size selection versus standard clinical group sizes for nonhuman primate QTc prolongation evaluation. Journal of Pharmacological & Toxicological Methods, 120, N.PAG. https://doi.org/10.1016/j.vascn.2023.107253

Chicago

Holdsworth, David, Derek D. Best, Katarina Haist, Kyle O’Donohue, Anson Phillips, Matthew M. Abernathy, Brian Roche, and Derek J. Leishman. 2023. “Comparison of Validity of Standard Nonclinical Group Size Selection versus Standard Clinical Group Sizes for Nonhuman Primate QTc Prolongation Evaluation.” Journal of Pharmacological & Toxicological Methods 120 (March): N.PAG. doi:10.1016/j.vascn.2023.107253.